Comparing once-weekly semaglutide to incretin-based therapies in patients with type 2 diabetes: a systematic review and meta-analysis.

Mishriky, B M

Comparing once-weekly semaglutide to incretin-based therapies in patients with type 2 diabetes: a systematic review and meta-analysis. [electronic resource] - Diabetes & metabolism 04 2019 - 102-109 p. digital

Publication Type: Comparative Study; Journal Article; Meta-Analysis; Systematic Review

1878-1780

10.1016/j.diabet.2018.09.002 doi


Adult
Blood Glucose--drug effects
Diabetes Mellitus, Type 2--blood
Dipeptidyl-Peptidase IV Inhibitors--administration & dosage
Drug Administration Schedule
Drug Therapy, Combination--adverse effects
Female
Glucagon-Like Peptide-1 Receptor--antagonists & inhibitors
Glucagon-Like Peptides--administration & dosage
Glycated Hemoglobin--analysis
Humans
Hypoglycemic Agents--administration & dosage
Incretins--administration & dosage
Male
Middle Aged
Randomized Controlled Trials as Topic--methods
Treatment Outcome